Skip to main content
. 2015 Jul 15;10(7):e0132564. doi: 10.1371/journal.pone.0132564

Table 2. Clinical outcomes of dUCBT recipients.

Outcome % (95% CI)
Cumulative Incidence of Grade II-IV aGVHD  
    at D100 12 (5.1, 21)
    at D180 13 (6.2, 23)
Cumulative Incidence of cGVHD  
    1-yr 17 (8.5, 27)
    2-yr 25 (15, 37)
5-yr Cumulative Incidence of  
    NRM 34 (22, 46)
    Relapse 41 (28, 53)
5-yr PFS 25 (15, 36)
5-yr OS 39 (26, 51)

Median f/u time among survivors: 70 months (range 32, 101)